WO2004032802A2 - Stent with improved flexibility - Google Patents

Stent with improved flexibility Download PDF

Info

Publication number
WO2004032802A2
WO2004032802A2 PCT/US2003/029434 US0329434W WO2004032802A2 WO 2004032802 A2 WO2004032802 A2 WO 2004032802A2 US 0329434 W US0329434 W US 0329434W WO 2004032802 A2 WO2004032802 A2 WO 2004032802A2
Authority
WO
WIPO (PCT)
Prior art keywords
seφentine
band
stent
peaks
circumferential
Prior art date
Application number
PCT/US2003/029434
Other languages
French (fr)
Other versions
WO2004032802A3 (en
Inventor
Paul F. Chouinard
Original Assignee
Scimed Life Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32068704&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2004032802(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scimed Life Systems, Inc. filed Critical Scimed Life Systems, Inc.
Priority to AU2003272556A priority Critical patent/AU2003272556A1/en
Priority to EP03754743A priority patent/EP1567088B1/en
Priority to DE60324833T priority patent/DE60324833D1/en
Priority to CA2495000A priority patent/CA2495000C/en
Priority to JP2004543316A priority patent/JP2006501942A/en
Publication of WO2004032802A2 publication Critical patent/WO2004032802A2/en
Publication of WO2004032802A3 publication Critical patent/WO2004032802A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541—Adjacent bands are arranged out of phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155—Adjacent bands being connected to each other
    • A61F2002/91558—Adjacent bands being connected to each other connected peak to peak

Definitions

  • Stents are placed or implanted within a variety of bodily vessels including in coronary arteries, renal arteries, peripheral arteries including illiac arteries, arteries of the neck and cerebral arteries, veins, biliary ducts, urethras, fallopian tubes, bronchial tubes, the trachea, the esophagus and the prostate.
  • Stents are available in a wide range of designs.
  • One popular stent design includes a plurality of serpentine rings having alternating peaks and troughs. Adjacent rings are interconnected via connecting elements. If adjacent rings are spaced too close together, however, binding, overlapping or interference can occur between adjacent rings on the inside of a bend due to the facing peaks and troughs moving toward each other and into contact.
  • the invention is directed to a stent comprising at least two serpentine circumferential bands including a first serpentine circumferential band and a second serpentine circumferential band.
  • Each serpentine circumferential band has alternating peaks and troughs.
  • the trough is not connected to the peak.
  • each connected peak-trough pair comprising a peak on the first serpentine circumferential band and a trough on the second serpentine circumferential band which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration and desirably when it is in a delivery configuration on a catheter.
  • the trough is connected to the peak.
  • the distance along the first serpentine circumferential band between each peak of a connected peak-trough pair and an adjacent peak of an unconnected peak-trough pair differs from the distance along the second se ⁇ entine circumferential band between the trough of the connected- trough pair and an adjacent trough of an unconnected peak-trough pair, the adjacent peak substantially opposite the adjacent trough.
  • peaks and troughs of unconnected peak-trough pairs are displaced relative to one another about the circumference of the stent.
  • the first and second serpentine circumferential bands are connected to one another via a plurality of longitudinal connectors.
  • the stent will have three or more of the serpentine circumferential bands, adjacent serpentine circumferential bands connected one to the other.
  • each connected peak-trough pair comprising a peak on one serpentine circumferential band and a trough on the adjacent serpentine circumferential band which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, and desirably in a delivery configuration on a catheter, the trough connected to the peak.
  • the distance along a serpentine circumferential band between each peak of a connected peak-trough pair and an adjacent peak of an unconnected peak-trough pair differs from the distance along the adjacent serpentine circumferential band between the trough of the connected-trough pair and an adjacent trough of an unconnected peak-trough pair, the adjacent peak substantially opposite the adjacent trough.
  • the invention is also directed to a-stent, comprising a plurality of se ⁇ entine circumferential bands comprising alternating peaks and troughs. Adjacent se ⁇ entine circumferential bands are connected to one another.
  • the se ⁇ entine circumferential bands include a first se ⁇ entine circumferential band, a second se ⁇ entine circumferential band and a third se ⁇ entine circumferential band.
  • the first se ⁇ entine circumferential band includes high peaks and low peaks.
  • the second se ⁇ entine circumferential band includes high peaks and low peaks, high troughs and low troughs.
  • the third se ⁇ entine circumferential band includes high troughs and low troughs.
  • the high peaks of the first se ⁇ entine circumferential band are substantially circumferentially aligned with the low troughs of the second se ⁇ entine circumferential band and the low peaks of the first se ⁇ entine circumferential band are substantially circumferentially aligned with the high troughs of the second se ⁇ entine circumferential band.
  • the high peaks of the second se ⁇ entine circumferential band are substantially circumferentially aligned with the low troughs of the third se ⁇ entine circumferential band and the low peaks of the second se ⁇ entine circumferential band are substantially circumferentially aligned with the high troughs of the third se ⁇ entine circumferential band.
  • the first se ⁇ entine circumferential band is interlaced with the second se ⁇ entine circumferential band and the second se ⁇ entine circumferential band is interlaced with the third se ⁇ entine circumferential band.
  • adjacent se ⁇ entine circumferential bands are connected to one another via a plurality of longitudinal connectors extending between substantially circumferentially aligned peaks and troughs.
  • each unconnected peak-trough pair comprising a peak on a se ⁇ entine circumferential band and a trough on the se ⁇ entine circumferential band adjacent thereto which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, and desirably in a delivery configuration on a catheter, the trough not connected to the peak.
  • each connected peak-trough pair comprising a peak on a se ⁇ entine circumferential band and a trough on the se ⁇ entine circumferential band adjacent thereto which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, and desirably in a delivery configuration on a catheter, the trough connected to the peak.
  • the distance along the se ⁇ entine circumferential band between each peak of a connected peak-trough pair and an adjacent peak of an unconnected peak-trough pair differs from the distance along the adjacent se ⁇ entine circumferential band between the trough of the connected-trough pair and an adjacent trough of an unconnected peak-trough pair, the adjacent peak substantially opposite the adjacent trough.
  • peaks and troughs of unconnected peak-trough pairs are displaced relative to one another about the circumference of the stent.
  • the invention is also directed to a stent having a proximal end and a distal end comprising a plurality of connected se ⁇ entine circumferential bands.
  • Each se ⁇ entine band comprises a plurality of struts arranged in alternating peaks and troughs. Adjacent se ⁇ entine circumferential bands are connected via a plurality of longitudinal connectors extending between peaks on one se ⁇ entine circumferential band and troughs on the se ⁇ entine circumferential band adjacent thereto.
  • each band comprises a repeating pattern of three or more struts of different lengths.
  • the struts of different lengths are also typically of different widths.
  • the stent is constructed and arranged to be self- expanding.
  • the invention is also directed to a stent comprising at least one circumferential se ⁇ entine band disposed about a longitudinal axis, the se ⁇ entine band comprising a plurality of struts, adjacent struts connected one to the other, the se ⁇ entine band having alternating peaks and troughs, the se ⁇ entine band including at least three peaks which are circumferentially and longitudinally offset from one another.
  • the stent will comprise a plurality of the circumferential se ⁇ entine band, adjacent circumferential se ⁇ entine bands connected to one another.
  • adjacent circumferential se ⁇ entine bands are connected to one another via two or more longitudinal connectors.
  • the stent is constructed such that unconnected peaks and troughs which are substantially circumferentially aligned prior to expansion of the stent are circumferentially displaced from one another on expansion of the stent.
  • the invention is also directed to a stent comprising at least one se ⁇ entine circumferential band which comprises a repeat pattern of three or more struts of different lengths.
  • the stent comprises a plurality of the se ⁇ entine band, adjacent bands connected to one another.
  • the struts are arranged in a pattern of alternating peaks and troughs.
  • the invention is also directed to a stent comprising at least two se ⁇ entine bands including a first se ⁇ entine band and a second se ⁇ entine band, each se ⁇ entine band having alternating peaks and troughs, the first se ⁇ entine band including connected peaks and unconnected peaks, the second se ⁇ entine band including connected troughs and unconnected troughs.
  • the peaks of the first se ⁇ entine band are substantially longitudinally aligned with the troughs of the second se ⁇ entine band when the stent is in an unexpanded state, and desirably in a delivery configuration on a catheter.
  • the connected peaks are connected to the connected troughs with connectors, each of the connectors having two ends which are substantially circumferentially aligned with one another in an unexpanded state, and desirably in a delivery configuration on a catheter.
  • the unconnected peaks of each band become circumferentially displaced from the unconnected troughs of an adjacent se ⁇ entine circumferential band, and the unconnected troughs of each se ⁇ entine circumferential band become circumferentially displaced from the unconnected peaks of each se ⁇ entine circumferential band on expansion of the stent.
  • the invention is also directed to a stent comprising at least two se ⁇ entine bands including a first se ⁇ entine band and a second se ⁇ entine band.
  • Each se ⁇ entine band has alternating peaks and troughs.
  • the first se ⁇ entine band includes connected peaks and unconnected peaks
  • the second se ⁇ entine band includes connected troughs and unconnected troughs.
  • the first and second se ⁇ entine bands have an identical number of peaks.
  • the peaks of the first se ⁇ entine band are substantially longitudinally aligned with the troughs of the second se ⁇ entine band when the stent is in an unexpanded state.
  • the connected peaks are connected to the connected troughs.
  • the stent comprises a third se ⁇ entine band having alternating peaks and troughs.
  • the first, second and third se ⁇ entine bands are arranged sequentially along the stent with the first se ⁇ entine band and the second se ⁇ entine band connected one to the other and defining a plurality of cells therebetween and the second se ⁇ entine band and the third se ⁇ entine band connected one to the other and defining a plurality of cells therebetween.
  • the first, second and third se ⁇ entine bands have the same number of peaks.
  • the stent has a first and second end region and a middle region extending therebetween wherein at least one of the first and second end regions of the stent has a different cell structure from the remainder of the stent.
  • the first and second end regions may have a cell structure which differs from one another.
  • Fig. la shows a flat view of an inventive stent.
  • Fig. lb shows a flat view of an inventive stent.
  • Fig. lc shows an enlarged view of a portion of the inventive stent of Fig. lb.
  • Fig. 2 shows a flat view of an inventive stent.
  • Fig. 3 shows a flat view of an inventive stent.
  • Fig. 4 shows a flat view of an inventive stent in an unexpanded configuration.
  • Fig. 5 shows a flat view of the stent of Fig. 4 in an expanded configuration.
  • Fig. 6a shows a flat view of another inventive stent.
  • Fig. 6b shows an enlarged end portion of the stent of Fig. 6a.
  • substantially circumferentially aligned does not require perfect circumferential alignment. Rather, it requires that at least a portion of a peak be circumferentially aligned with a portion of a trough on an adjacent se ⁇ entine circumferential band.
  • substantially circumferentially aligned peaks and troughs include but are not limited to facing peak 16' and trough 18' connected by longitudinal connector 24 shown in Figs, la, 2 and 3 and facing peak 16b' and trough 18b 1 connected by longitudinal connector 24 shown in Fig. 5, as well as facing peak 16" and trough 18" shown in the circled regions of Figs. 1-3.
  • the term 'longitudinally staggered' when used in reference to peaks or troughs within a se ⁇ entine circumferential band refers to peaks or troughs with the band which extend to different positions lengthwise along the length of the stent.
  • longitudinally staggered peaks within a se ⁇ entine circumferential band include but are not limited to peaks 16' and 16" within a band as shown in Figs. 1- 3.
  • Examples of longitudinally staggered troughs within a se ⁇ entine circumferential band include but are not limited to troughs 18' and 18" within a band as shown in Figs. 1-3.
  • Longitudinally aligned peaks or troughs extend to the same location lengthwise along the stent. Examples of longitudinally aligned peaks or troughs are shown in the proximal end and distal ends of the stent of Fig. 2. Other examples include all peaks 16' within a se ⁇ entine band.
  • distal' refers to the end of the stent which is inserted first into the body.
  • proximal' refers to the end of the stent which is inserted last into the body. It is within the scope of the invention that the orientation of any of the inventive stents disclosed herein can be reversed so that either end may be delivered into the body first.
  • a flat view of an inventive stent is shown.
  • the stent has a distal end 10 and a proximal end 12 and comprises a plurality of se ⁇ entine circumferential bands 20.
  • Each band comprises a plurality of interconnected struts and includes struts of three different lengths.
  • the first strut 14a is shorter and narrower than second strut 14b and third strut 14c.
  • Third strut 14c is longer and wider that first strut 14a and second strut 14b.
  • the struts 14a-c are arranged in a repeating pattern such that the circumferentially adjacent peaks 16 within each band 20 terminate at different longitudinal points along the stent and the circumferentially adjacent troughs 18 within each band 20 terminate at different longitudinal points along the stent.
  • Adjacent se ⁇ entine circumferential bands are connected to one another in at least one and desirably, as shown in Fig. la, a plurality of locations.
  • the connections between adjacent se ⁇ entine circumferential bands are in the form of longitudinal connectors 24 which extend between peaks 16 on one band and substantially circumferentially aligned troughs 18 on an adjacent band.
  • circumferentially adjacent connectors 20 are separated by a path along one se ⁇ entine circumferential band which traverses at least two peaks of the se ⁇ entine circumferential band and by a path along the adjacent se ⁇ entine circumferential band which traverses at least two troughs of the adjacent se ⁇ entine circumferential band.
  • the invention allows for more peaks or fewer and/or more troughs or fewer troughs between adjacent connectors of any of the embodiments disclosed herein.
  • the stent is further constructed so that in the unexpanded configuration, and desirably in a delivery configuration, peaks of one se ⁇ entine circumferential band are substantially circumferentially aligned with troughs of an adjacent se ⁇ entine circumferential band.
  • adjacent se ⁇ entine circumferential bands 20 are interconnected via a plurality of connectors 24 whose first and second ends are circumferentially and longitudinally offset from one another.
  • connectors 24 are substantially linear.
  • Non-linear connectors, including curved connectors, connectors having curved portions and connectors having angled portions, may also used if space permits.
  • Connectors 24 may be seen in greater detail in Fig. lc which is an enlargement of a portion of the stent of Fig. lb. The connectors are shown with hatch marks in Fig. lc.
  • connectors 24 are at an oblique angle relative to the longitudinal axis of the stent, they are, nevertheless, substantially parallel to the longitudinal axis of the stent. It is within the of the invention to provide embodiments in which connectors 24 are disposed at a more substantial angle relative to the longitudinal axis of the stent so that the connectors are not substantially parallel to the longitudinal axis of the stent.
  • the connectors of Fig. lb may also be longer, depending on the separation between adjacent se ⁇ entine circumferential bands.
  • the stent of Figs, lb and lc is similar to that of Fig. la.
  • Both stents have three types of struts 14a- 14c of increasing length and width. Both have connected pairs of peaks and trough 16' and 18' as well as unconnected pairs of substantially circumferentially aligned and unconnected peaks 16" and troughs 18".
  • the struts are distributed such that on expansion of the stent, unconnected but substantially circumferentially aligned peaks and troughs are displaced relative to one another about the circumference of the stent.
  • each se ⁇ entine circumferential band comprises three types of struts of different length, struts 14a- 14c.
  • the peaks are arranged circumferentially in a repeat pattern of two longitudinally aligned adjacent peaks and one shorter peak adjacent to the two aligned peaks.
  • the troughs are arranged circumferentially in a repeat pattern of two longitudinally aligned adjacent troughs and one longer trough adjacent to the two aligned troughs.
  • the struts within the se ⁇ entine circumferential bands are arranged such that when the stent is in an unexpanded state, peaks on one band are substantially circumferentially aligned with troughs on an adjacent substantially circumferential band. Upon expansion of the stent, peaks and troughs which were substantially circumferentially aligned with one another will be displaced circumferentially relative to one another.
  • the proximal-most and distal-most se ⁇ entine circumferential bands of the stent of Fig. 2 differ from that of Fig. la in that the troughs of the proximal-most se ⁇ entine circumferential band are aligned with another and the peaks of the distal- most se ⁇ entine circumferential band are aligned with another, unlike in the stent of Fig. la. Moreover, the peaks in the proximal-most se ⁇ entine circumferential band are arranged in a repeating pattern of two longer peaks followed by one shorter peak and the troughs in the distal-most se ⁇ entine circumferential band are arranged in a repeating pattern of one longer trough and two shorter troughs.
  • the stent of Fig. 2 is similar to the stent of Fig. la in that the number of connections between the adjacent se ⁇ entine circumferential bands is constant along the length of the stent. Also, the frequency of connections between the adjacent se ⁇ entine circumferential bands is constant along the length of the stent as is the spacing of the connections about the circumference of the stent.
  • Another inventive stent is shown in Fig. 3.
  • the stent of Fig. 3 is similar to the stent of Fig, 2 but differs in that troughs in the proximal-most se ⁇ entine circumferential band are not longitudinally aligned with one another.
  • the peaks in the distal-most se ⁇ entine circumferential band are not longitudinally aligned -with one another. Rather, the proximal-most and distal-most se ⁇ entine circumferential bands of the stent are of the same construction as the remainder of the se ⁇ entine circumferential bands in the stent.
  • Fig. 4 shows a flat view of an inventive stent in an unexpanded configuration.
  • the unconnected peaks 16" of each band proximal to the distal most band are substantially circumferentially aligned with the unconnected troughs 18" of an adjacent band 20.
  • the struts 14a-c are of three lengths and widths.
  • the stent of Fig. 4 is shown in an expanded configuration in Fig. 5.
  • unconnected peaks 16" and unconnected troughs 18" which were previously substantially circumferentially aligned with one another are now displaced circumferentially, relative to one another.
  • a similar circumferential displacement between unconnected but substantially circumferentially aligned peaks and troughs occurs in the other stents disclosed herein as well.
  • FIG. 6a and 6b An inventive stent with special ends is shown in the flat in Figs. 6a and 6b.
  • the stent of Figs. 6a and 6b has an increased number of connectors extending between adjacent se ⁇ entine circumferential bands at the ends of the stent. Specifically, each peak on the proximal-most se ⁇ entine circumferential band is connected to a trough on the adjacent se ⁇ entine circumferential band and each trough on the distal-most se ⁇ entine circumferential band is connected to a peak on the adjacent se ⁇ entine circumferential band.
  • the connectivity results in plurality of larger and smaller substantially diamond-shaped cells 25a and 25b (shown with hatching) which serves to stabilize the end of the stent.
  • the stent of Figs. 6a and 6b may be modified in numerous ways. In one modification, only one end of the stent is provided with the additional connectors so that only one end of the stent has the large cell/small cell structure shown in Figs. 6a and 6b. In another modification, at one or both ends of the stent three or more adjacent se ⁇ entine circumferential bands are interconnected with additional or fewer connectors as compared with the remainder of the stent. Thus, the resulting stent has multiple adjacent rows of large and small diamond cells at one or both ends of the stent. Also, the ratio of connectors to peaks may be other than the 1:1 ratio provided at the end of the stent of Fig. 6a and other than the ratio of 1 :3 provided in Fig. la.
  • the stent of Fig. la is designed such that the expansion proceeds in the same way whether the stent is deployed from the proximal to the distal end or vice versa.
  • each se ⁇ entine circumferential band is characterized by a path length about the periphery of the stent. This path length corresponds to the length that the band would have if cut open and stretched out into a line. Desirably, as shown in Figs. 1-6, each of the se ⁇ entine circumferential bands is of the same total pathlength. The invention also contemplates embodiment in which the se ⁇ entine bands are not all of the same pathlength. To the extent that the stent has pathlengths of different length, the different length pathways are desirably provided only at one or both ends of the stent. In the inventive stents disclosed in Figs.
  • the se ⁇ entine circumferential bands all have the same number of peaks and the same number of troughs.
  • the invention also contemplates embodiments which include bands of different numbers of peaks and troughs, to the extent that such bands are present, it is desirable that they be present only at one or both ends of the stent.
  • the stents of Figs. 1-6 are considered to comprise se ⁇ entine circumferential bands, each of which comprises a plurality of interconnected struts, it is noted that all of the bands have the same number of struts.
  • the invention also contemplates embodiments having the presence of some se ⁇ entine circumferential bands which have more or fewer struts than other of the se ⁇ entine circumferential bands. Desirably, however, the bands having different numbers of struts are provided only at one or both ends of the stent.
  • the inventive stents may also be considered to compromise a plurality of interconnected cells.
  • the stent comprises a plurality of rows of interconnected cells 27' and 27".
  • Cells 27' and 27" are identical in area and shape but extend in opposite helical directions about the longitudinal axis of the stent.
  • Each cell is defined by first and second paths which are connected to one another by connectors.
  • Cell 27' for example, has a first path 31' and a second path 33' connected by connectors 24.
  • the first path forms a part of a se ⁇ entine circumferential band and the second path form a part of another se ⁇ entine circumferential band.
  • the first and second paths at the ends of a cell are of the same pathlength.
  • the first and second paths of a cell also have the same number of struts.
  • the arrangement of the struts in the first and second paths differ from one another resulting in peak- trough pairs within a cell which are substantially circumferentially aligned in an unexpanded state and desirably in a delivery configuration on a catheter and which are circumferentially displaced relative to one another on expansion of the stent.
  • cells 27' and 27" are oriented in opposite helical directions about the longitudinal axis of the stent.
  • three types of cells 27', 27" and 27'" are present as a result of the alignment of the peaks at one end and the troughs at the other end of the stent.
  • only a single type of cell 27' is present.
  • cells 25a and 25b at the ends of the stent are substantially diamond shape whereas the remaining cells 27' are not substantially diamond shaped.
  • the inventive stents of Figs. 1-6 allow for pairs of unconnected peaks and troughs on adjacent bands to be substantially aligned in an unexpanded state, and desirably in the delivery configuration, while allowing for the unconnected peaks and troughs to be displaced circumferentially relative to one another on expansion of the stent.
  • This is achieved, using se ⁇ entine circumferential bands of equal path length and/or equal numbers of peaks, by arranging the struts of the stent such that the path length between a connected peak and a circumferentially adjacent connected peak on a first se ⁇ entine band is different from the path length along an adjacent se ⁇ entine band between the corresponding connected trough and the corresponding unconnected trough.
  • the summed length of the two struts immediately circumferentially adjacent to a connected peak is different than the summed length of the two struts immediately adjacent the corresponding connected trough as the circumference of the stent is traversed in a given direction.
  • the invention is also directed to a stent having a proximal end and a distal end comprising a plurality of connected se ⁇ entine circumferential bands.
  • Each se ⁇ entine band comprises a plurality of struts arranged in alternating peaks and troughs. Adjacent se ⁇ entine circumferential bands are connected via a plurality of longitudinal connectors extending between peaks on one se ⁇ entine circumferential band and troughs on the se ⁇ entine circumferential band adjacent thereto.
  • each band comprises a repeating pattern of three or more struts of different lengths.
  • the struts of different lengths are also typically of different widths.
  • the stent is constructed and arranged to be self- expanding.
  • the invention is also directed to a stent comprising at least one circumferential se ⁇ entine band disposed about a longitudinal axis, the se ⁇ entine band comprising a plurality of struts, adjacent struts connected one to the other, the se ⁇ entine band having alternating peaks and troughs, the se ⁇ entine band including at least three peaks which are circumferentially and longitudinally offset from one another.
  • the stent will comprise a plurality of the circumferential se ⁇ entine band, adjacent circumferential se ⁇ entine bands connected to one another.
  • adjacent circumferential se ⁇ entine bands are connected to one another via two or more longitudinal connectors. More desirably, the stent is constructed such that unconnected peaks and troughs which are substantially chcumferentially aligned prior to expansion of the stent are circumferentially displaced from one another on expansion of the stent.
  • the invention is also directed to a stent comprising at least one se ⁇ entine circumferential band which comprises a repeat pattern of three or more struts of different lengths.
  • the stent comprises a plurality of the se ⁇ entine band, adjacent bands connected to one another.
  • the struts are arranged in a pattern of alternating peaks and troughs.
  • the invention is also directed to a stent comprising at least two se ⁇ entine bands including a first se ⁇ entine band and a second se ⁇ entine band, each se ⁇ entine band having alternating peaks and troughs, the first se ⁇ entine band including connected peaks and unconnected peaks, the second se ⁇ entine band including connected troughs and unconnected froughs.
  • the peaks of the first se ⁇ entine band are substantially longitudinally aligned with the troughs of the second se ⁇ entine band when the stent is in an unexpanded state.
  • the connected peaks are connected to the connected troughs with connectors, each of the connectors having two ends which are substantially longitudinally aligned with one another in at least the unexpanded state.
  • each band becomes circumferentially displaced from the unconnected froughs of an adjacent se ⁇ entine circumferential band
  • the unconnected troughs of each se ⁇ entine circumferential band become circumferentially displaced from the unconnected peaks of each se ⁇ entine circumferential band on expansion of the stent.
  • the invention is also directed to a stent comprising at least two se ⁇ entine bands, such as that shown by way of non-limiting example in Figs. 6a and 6b, including a first se ⁇ entine band and a second se ⁇ entine band.
  • Each se ⁇ entine band has alternating peaks and troughs.
  • the first se ⁇ entine band includes connected peaks and unconnected peaks, and the second se ⁇ entine band includes connected troughs and unconnected troughs.
  • the first and second se ⁇ entine bands have an identical number of peaks.
  • the peaks of the first se ⁇ entine band are substantially longitudinally aligned with the troughs of the second se ⁇ entine band when the stent is in an unexpanded state.
  • the connected peaks are connected to the connected troughs.
  • the unconnected peaks of each band become circumferentially displaced from the unconnected froughs of an adjacent band, and the unconnected troughs of each band become circumferentially displaced from the unconnected peaks of an adjacent band on expansion of the stent.
  • the first and second se ⁇ entine bands may be of different total pathlength about the stent.
  • the stent comprises a third se ⁇ entine band having alternating peaks and troughs.
  • the first, second and third se ⁇ entine bands are arranged sequentially along the stent with the first se ⁇ entine band and the second se ⁇ entine band connected one to the other and defining a plurality of cells therebetween and the second se ⁇ entine band and the third se ⁇ entine band connected one to the other and defining a plurality of cells therebetween.
  • the first, second and third se ⁇ entine bands have the same number of peaks.
  • tbs stent has a first and second end region and a middle region extending therebetween wherein at least one of the first and second end regions of the stent has a different cell structure from the remainder of the stent.
  • the first and second end regions may have a cell structure which differs from one another.
  • the invention is also directed to helical stents.
  • One or more helical bands may be provided where the peaks and troughs on it are arranged such that some of the peaks are substantially circumferentially aligned and connected to some of the troughs on an adjacent turn of the helical band or on an adjacent helical band and other substantially circumferentially aligned peaks and troughs on adjacent bands or adjacent turns of a band are not connected to one another.
  • the non- connected substantially circumferentially aligned peaks and troughs are chcumferentially displaced from one another. This may be achieved with an appropriate arrangement of struts.
  • any of the inventive stents disclosed herein may also be provided in a 'jelly roll' configuration.
  • the flat pattern of Fig. 1 may be rolled into a tube without securing the longitudinal edges to one another.
  • Such a stent would be deployed by unrolling and expansion of the cells or bands which extend about the longitudinal axis of the stent.
  • An example of such a stent is disclosed in WO0132099.
  • inventive stents disclosed herein may also be provided in an embodiments in which the longitudinal connectors may be shorter or longer than those shown in Fig. 1 a or any of the other figures disclosed herein.
  • the longitudinal connectors may be shorter or longer than those shown in Fig. 1 a or any of the other figures disclosed herein.
  • facing peaks and troughs which are connected to one another may abut one another and the connector may be in the form of a small weld or an overlap region between the facing peak and frough.
  • connector which are curved may be used to connect facing peaks and troughs.
  • the connectors may also be located offset from the peaks and troughs.
  • the invention is also directed to stents such as those disclosed herein with sidebranch access.
  • a stent may be provided by omitting one or more struts in one or more desired regions of the stent.
  • Sidebranch access may also be provided by omitting a first se ⁇ entine band and providing connectors between some, but not all of the peaks and troughs of the resulting adjacent second se ⁇ entine bands.
  • Sidebranch access may further be achieved in any of the inventive stents disclosed herein by alternating the location of connectors between adjacent se ⁇ entine bands. For example, where it is desirable to provide for sidebranch access, fewer connections between adjacent bands may be provided.
  • Sidebranch access may also be provided by including adjacent se ⁇ entine bands of different total pathlength. In such a case, it is desirable although not necessary that the adjancent se ⁇ entine bands have the same number of peaks.
  • inventive stents disclosed herein may also be used in bifurcated stents.
  • the trunk and/or any of the branches may be provided with stents having the novel designs disclosed herein.
  • any of the inventive stents disclosed above may be provided with a uniform diameter or may taper in portions or along the entire length of the stent.
  • the width and/or thickness of the various portions of the inventive stents may increase or decrease along a given portion of the stent.
  • the width and/or thickness of the struts, se ⁇ entine bands and/or longitudinal connectors may increase or decrease along portions of the stent or along the entire length of the stent.
  • the amplitude and/or wavelength of several successive first se ⁇ entine bands may remain constant while the width and/or thickness of the successive first se ⁇ entine bands decreases.
  • the amplitude and/or wavelength of several successive second se ⁇ entine bands may remain constant while the width and/or thickness of the successive second se ⁇ entine bands decreases.
  • the amplitude and/or wavelength of several successive first se ⁇ entine bands may decrease or increase while the width and/or thickness of the successive first se ⁇ entine bands remains constant.
  • the amplitude and/or wavelength of several successive second se ⁇ entine bands may or decrease or increase while the width and/or thickness of the successive second se ⁇ entine bands remain constant.
  • the amplitude of the stent could also be increased or decrease along with the thickness and/or width of the stent.
  • the inventive stents may be manufactured using known stent manufacturing techniques.
  • Suitable methods for manufacturing the inventive stents include laser cutting, chemical etching or stamping of a tube.
  • the inventive stents may also be manufactured by laser cutting, chemically etching, stamping a flat sheet, rolling the sheet and welding the sheet, by electrode discharge machining, or by molding the stent with the desired design.
  • Any suitable stent material may be used in the manufacture of the inventive stents. Examples of such materials include polymeric materials, metals, ceramics and composites. Suitable polymeric materials include thermotropic liquid crystal polymers (LCP's). Where the stent is made of metal, the metal may be stainless steel, cobalt chrome alloys such as elgiloy, tantalum o other plastically deformable metals.
  • first se ⁇ entine band and the second se ⁇ entine band may be made of different materials.
  • the connectors may be made of a different material than the first and/or second se ⁇ entine bands.
  • the inventive stents desirably are provided in self-expanding form. To that end, they may be constructed from shape memory materials including Nitinol.
  • the self-expanding embodiments of the invention allow for a controlled expansion of the stent as explained below.
  • self-expanding stents are restrained on a catheter in an unexpanded configuration via a sheath. As the sheath is withdrawn, the newly freed portions of the stent will self-expand.
  • each se ⁇ entine circumferential band will be freed from the sheath in several waves - the first wave of peaks, corresponding to the longest peaks will expand first, followed by a wave of peaks which are shorter expanding until the se ⁇ entine is expanded.
  • the inventive stents may also be provided in balloon expandable form, or as a hybrid, having self-expanding characteristics and balloon expandable characteristics.
  • the inventive stents may include suitable radiopaque coatings.
  • the stents may be coated with gold or other noble metals or sputtered with tantalum or other metals.
  • the stents may also be made directly from a radiopaque material to obviate the need for a radiopaque coating or may be made of a material having a radiopaque inner core.
  • Other radiopaque metals which may be used include platinum, platinum tungsten, palladium, platinum iridium, rhodium, tantalum, or alloys or composites of these metals.
  • inventive stents may also be provided with various bio-compatible coatings to enhance various properties of the stent.
  • the inventive stents may be provided with lubricious coatings.
  • the inventive stents may also be provided with drug-containing coatings which release drugs over time.
  • inventive stents may also be provided with a sugar or more generally a carbohydrate and/or a gelatin to maintain the stent on a balloon during delivery of the stent to a desired bodily location.
  • suitable compounds for treating the stent include biodegradable polymers and polymers which are dissolvable in bodily fluids.
  • Portions of the interior and/or exterior of the stent may be coated or impregnated with the compound.
  • Mechanical retention devices may also be used to maintain the stent on the balloon during delivery.
  • the inventive stents may also be used as the framework for a graft or may have a liner disposed therein.
  • Suitable coverings and liners include nylon, collagen, PTFE and expanded PTFE, polyethylene terephthalate and KENLAR, or any of the materials disclosed in US 5,824,046 and US 5,755,770. More generally, any known graft material may be used including synthetic polymers such as polyethylene, polypropylene, polyurethane, polyglycolic acid, polyesters, polyamides, their mixtures, blends, copolymers, mixtures, blends and copolymers.
  • the inventive stents may find use in coronary arteries, renal arteries, peripheral arteries including illiac arteries, arteries of the neck and cerebral arteries.
  • the stents of the present invention are not limited to use in the vascular system and may also be advantageously employed in other body structures, including but not limited to arteries, veins, biliary ducts, urethras, fallopian tubes, bronchial tubes, the trachea, the esophagus and the prostate.
  • the invention is also directed to stent delivery catheters with stents such as those disclosed herein disposed about a portion of the catheter.
  • the invention is also directed to methods of delivering any of the stents disclosed herein.
  • the methods comprise delivering a catheter with an inventive stent disclosed herein disposed thereabout to a desired bodily location and expanding the stent or allowing the stent to expand.
  • the stent is self-expanding and a sheath which restrains the stent is removed from about the stent. As the sheath is removed, waves of peaks from a given se ⁇ entine circumferential band are freed to self- expand.
  • the catheter Upon deployment of the stent, the catheter is removed from the body.
  • any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims).
  • the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below (e.g.
  • the above Examples and disclosure are intended to be illustrative and not exhaustive. These examples and this description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.
  • This PCT application claims priority from US Application No. 10/269,111, filed on October 9, 2002, the entire contents of which is hereby inco ⁇ orated by reference.

Abstract

A stent comprises a plurality of connected serpentine circumferential bands (20). Adjacent serpentine circumferential bands are connected via a plurality of longitudinal connectors (24) extending between peaks (16) on one serpentine circumferential band and troughs (18) on the serpentine circumferential band adjacent thereto. The struts (14) of the serpentine bands are arranged such that on expansion of the stent, peaks and troughs which are substantially circumferentially aligned with one another, but not connected with one another, on adjacent serpentine circumferential bands are circumferentially displaced from one another.

Description

STENT WITH IMPROVED FLEXIBILITY
Background of the Invention
Stents are placed or implanted within a variety of bodily vessels including in coronary arteries, renal arteries, peripheral arteries including illiac arteries, arteries of the neck and cerebral arteries, veins, biliary ducts, urethras, fallopian tubes, bronchial tubes, the trachea, the esophagus and the prostate.
Stents are available in a wide range of designs. One popular stent design includes a plurality of serpentine rings having alternating peaks and troughs. Adjacent rings are interconnected via connecting elements. If adjacent rings are spaced too close together, however, binding, overlapping or interference can occur between adjacent rings on the inside of a bend due to the facing peaks and troughs moving toward each other and into contact.
There remains a need for innovative, flexible stents which are designed so that interference between adjacent rings does not substantially occur.
Without limiting the scope of the invention a brief summary of some of the claimed embodiments of the invention is set forth below. Additional details of the summarized embodiments of the invention and/or additional embodiments of the invention may be found in the Detailed Description of the Invention below. A brief abstract of the technical disclosure in the specification is provided as well for the purposes of complying with 37 C.F.R. 1.72.
All US patents and applications and all other published documents mentioned anywhere in this application are incorporated herein by reference in their entirety.
Summary of the Invention
In one embodiment, the invention is directed to a stent comprising at least two serpentine circumferential bands including a first serpentine circumferential band and a second serpentine circumferential band. Each serpentine circumferential band has alternating peaks and troughs. There is a plurality of unconnected peak- trough pairs with each unconnected peak-trough pair comprising a peak on the first serpentine circumferential band and a trough on the second serpentine circumferential band which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration and desirably when it is in a delivery configuration on a catheter. The trough is not connected to the peak. There also is a plurality of connected peak-trough pairs with each connected peak-trough pair comprising a peak on the first serpentine circumferential band and a trough on the second serpentine circumferential band which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration and desirably when it is in a delivery configuration on a catheter. The trough is connected to the peak. The distance along the first serpentine circumferential band between each peak of a connected peak-trough pair and an adjacent peak of an unconnected peak-trough pair differs from the distance along the second seφentine circumferential band between the trough of the connected- trough pair and an adjacent trough of an unconnected peak-trough pair, the adjacent peak substantially opposite the adjacent trough. As the stent expands, peaks and troughs of unconnected peak-trough pairs are displaced relative to one another about the circumference of the stent.
Desirably, the first and second serpentine circumferential bands are connected to one another via a plurality of longitudinal connectors.
Typically, the stent will have three or more of the serpentine circumferential bands, adjacent serpentine circumferential bands connected one to the other. There will be a plurality of unconnected peak-trough pairs along adjacent serpentine circumferential bands, each unconnected peak-trough pair comprising a peak on one serpentine circumferential band and a trough on the adjacent serpentine circumferential band which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, and desirably in a delivery configuration on a catheter, the trough not connected to the peak. There will also be a plurality of connected peak-trough pairs along adjacent serpentine circumferential bands, each connected peak-trough pair comprising a peak on one serpentine circumferential band and a trough on the adjacent serpentine circumferential band which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, and desirably in a delivery configuration on a catheter, the trough connected to the peak. The distance along a serpentine circumferential band between each peak of a connected peak-trough pair and an adjacent peak of an unconnected peak-trough pair differs from the distance along the adjacent serpentine circumferential band between the trough of the connected-trough pair and an adjacent trough of an unconnected peak-trough pair, the adjacent peak substantially opposite the adjacent trough. The invention is also directed to a-stent, comprising a plurality of seφentine circumferential bands comprising alternating peaks and troughs. Adjacent seφentine circumferential bands are connected to one another. The seφentine circumferential bands include a first seφentine circumferential band, a second seφentine circumferential band and a third seφentine circumferential band. The first seφentine circumferential band includes high peaks and low peaks. The second seφentine circumferential band includes high peaks and low peaks, high troughs and low troughs. The third seφentine circumferential band includes high troughs and low troughs. The high peaks of the first seφentine circumferential band are substantially circumferentially aligned with the low troughs of the second seφentine circumferential band and the low peaks of the first seφentine circumferential band are substantially circumferentially aligned with the high troughs of the second seφentine circumferential band. Also the high peaks of the second seφentine circumferential band are substantially circumferentially aligned with the low troughs of the third seφentine circumferential band and the low peaks of the second seφentine circumferential band are substantially circumferentially aligned with the high troughs of the third seφentine circumferential band. Desirably, the first seφentine circumferential band is interlaced with the second seφentine circumferential band and the second seφentine circumferential band is interlaced with the third seφentine circumferential band. Desirably, adjacent seφentine circumferential bands are connected to one another via a plurality of longitudinal connectors extending between substantially circumferentially aligned peaks and troughs.
Typically, there will be a plurality of unconnected peak-trough pairs, each unconnected peak-trough pair comprising a peak on a seφentine circumferential band and a trough on the seφentine circumferential band adjacent thereto which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, and desirably in a delivery configuration on a catheter, the trough not connected to the peak. There will also be a plurality of connected peak- trough pairs, each connected peak-trough pair comprising a peak on a seφentine circumferential band and a trough on the seφentine circumferential band adjacent thereto which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, and desirably in a delivery configuration on a catheter, the trough connected to the peak. The distance along the seφentine circumferential band between each peak of a connected peak-trough pair and an adjacent peak of an unconnected peak-trough pair differs from the distance along the adjacent seφentine circumferential band between the trough of the connected-trough pair and an adjacent trough of an unconnected peak-trough pair, the adjacent peak substantially opposite the adjacent trough. As the stent expands, peaks and troughs of unconnected peak-trough pairs are displaced relative to one another about the circumference of the stent.
The invention is also directed to a stent having a proximal end and a distal end comprising a plurality of connected seφentine circumferential bands. Each seφentine band comprises a plurality of struts arranged in alternating peaks and troughs. Adjacent seφentine circumferential bands are connected via a plurality of longitudinal connectors extending between peaks on one seφentine circumferential band and troughs on the seφentine circumferential band adjacent thereto. The struts of the seφentine bands are arranged such that on expansion of the stent, peaks and troughs which are substantially circumferentially aligned with one another, but not connected with one another, on adjacent seφentine circumferential bands are circumferentially displaced from one another. Typically, each band comprises a repeating pattern of three or more struts of different lengths. The struts of different lengths are also typically of different widths. Desirably, the stent is constructed and arranged to be self- expanding. The invention is also directed to a stent comprising at least one circumferential seφentine band disposed about a longitudinal axis, the seφentine band comprising a plurality of struts, adjacent struts connected one to the other, the seφentine band having alternating peaks and troughs, the seφentine band including at least three peaks which are circumferentially and longitudinally offset from one another. Typically, the stent will comprise a plurality of the circumferential seφentine band, adjacent circumferential seφentine bands connected to one another. Desirably, adjacent circumferential seφentine bands are connected to one another via two or more longitudinal connectors. More desirably, the stent is constructed such that unconnected peaks and troughs which are substantially circumferentially aligned prior to expansion of the stent are circumferentially displaced from one another on expansion of the stent. The invention is also directed to a stent comprising at least one seφentine circumferential band which comprises a repeat pattern of three or more struts of different lengths. Desirably, the stent comprises a plurality of the seφentine band, adjacent bands connected to one another. The struts are arranged in a pattern of alternating peaks and troughs.
The invention is also directed to a stent comprising at least two seφentine bands including a first seφentine band and a second seφentine band, each seφentine band having alternating peaks and troughs, the first seφentine band including connected peaks and unconnected peaks, the second seφentine band including connected troughs and unconnected troughs. The peaks of the first seφentine band are substantially longitudinally aligned with the troughs of the second seφentine band when the stent is in an unexpanded state, and desirably in a delivery configuration on a catheter. The connected peaks are connected to the connected troughs with connectors, each of the connectors having two ends which are substantially circumferentially aligned with one another in an unexpanded state, and desirably in a delivery configuration on a catheter. The unconnected peaks of each band become circumferentially displaced from the unconnected troughs of an adjacent seφentine circumferential band, and the unconnected troughs of each seφentine circumferential band become circumferentially displaced from the unconnected peaks of each seφentine circumferential band on expansion of the stent.
The invention is also directed to a stent comprising at least two seφentine bands including a first seφentine band and a second seφentine band. Each seφentine band has alternating peaks and troughs. The first seφentine band includes connected peaks and unconnected peaks, and the second seφentine band includes connected troughs and unconnected troughs. The first and second seφentine bands have an identical number of peaks. The peaks of the first seφentine band are substantially longitudinally aligned with the troughs of the second seφentine band when the stent is in an unexpanded state. The connected peaks are connected to the connected troughs. The unconnected peaks of each band become circumferentially displaced from the unconnected troughs of an adjacent band, and the unconnected troughs of each band become circumferentially displaced from the unconnected peaks of an adjacent band on expansion of the stent. Desirably, the stent comprises a third seφentine band having alternating peaks and troughs. The first, second and third seφentine bands are arranged sequentially along the stent with the first seφentine band and the second seφentine band connected one to the other and defining a plurality of cells therebetween and the second seφentine band and the third seφentine band connected one to the other and defining a plurality of cells therebetween. The first, second and third seφentine bands have the same number of peaks.
More desirably, the stent has a first and second end region and a middle region extending therebetween wherein at least one of the first and second end regions of the stent has a different cell structure from the remainder of the stent. Optionally, the first and second end regions may have a cell structure which differs from one another.
Additional details and/or embodiments of the invention are discussed below.
Brief Description of the Figures
Fig. la shows a flat view of an inventive stent.
Fig. lb shows a flat view of an inventive stent.
Fig. lc shows an enlarged view of a portion of the inventive stent of Fig. lb.
Fig. 2 shows a flat view of an inventive stent.
Fig. 3 shows a flat view of an inventive stent.
Fig. 4 shows a flat view of an inventive stent in an unexpanded configuration. Fig. 5 shows a flat view of the stent of Fig. 4 in an expanded configuration.
Fig. 6a shows a flat view of another inventive stent.
Fig. 6b shows an enlarged end portion of the stent of Fig. 6a.
Detailed Description of the Invention
This invention may be embodied in many different forms. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
For the puφoses of this disclosure, unless otherwise indicated, identical reference numerals used in different figures refer to the same component.
Also, the phrase 'substantially circumferentially aligned' as used herein does not require perfect circumferential alignment. Rather, it requires that at least a portion of a peak be circumferentially aligned with a portion of a trough on an adjacent seφentine circumferential band. Examples of substantially circumferentially aligned peaks and troughs include but are not limited to facing peak 16' and trough 18' connected by longitudinal connector 24 shown in Figs, la, 2 and 3 and facing peak 16b' and trough 18b1 connected by longitudinal connector 24 shown in Fig. 5, as well as facing peak 16" and trough 18" shown in the circled regions of Figs. 1-3. Further, the term 'longitudinally staggered' when used in reference to peaks or troughs within a seφentine circumferential band refers to peaks or troughs with the band which extend to different positions lengthwise along the length of the stent. Examples of longitudinally staggered peaks within a seφentine circumferential band include but are not limited to peaks 16' and 16" within a band as shown in Figs. 1- 3. Examples of longitudinally staggered troughs within a seφentine circumferential band include but are not limited to troughs 18' and 18" within a band as shown in Figs. 1-3. Longitudinally aligned peaks or troughs extend to the same location lengthwise along the stent. Examples of longitudinally aligned peaks or troughs are shown in the proximal end and distal ends of the stent of Fig. 2. Other examples include all peaks 16' within a seφentine band.
The term 'distal' as used herein in reference to the distal end of a stent refers to the end of the stent which is inserted first into the body. The term 'proximal' as used herein in reference to the proximal end of a stent refers to the end of the stent which is inserted last into the body. It is within the scope of the invention that the orientation of any of the inventive stents disclosed herein can be reversed so that either end may be delivered into the body first.
In Fig. la, a flat view of an inventive stent is shown. The stent has a distal end 10 and a proximal end 12 and comprises a plurality of seφentine circumferential bands 20. Each band comprises a plurality of interconnected struts and includes struts of three different lengths. As shown, the first strut 14a is shorter and narrower than second strut 14b and third strut 14c. Third strut 14c is longer and wider that first strut 14a and second strut 14b. The struts 14a-c are arranged in a repeating pattern such that the circumferentially adjacent peaks 16 within each band 20 terminate at different longitudinal points along the stent and the circumferentially adjacent troughs 18 within each band 20 terminate at different longitudinal points along the stent.
Adjacent seφentine circumferential bands are connected to one another in at least one and desirably, as shown in Fig. la, a plurality of locations. In the stent of Fig. la, the connections between adjacent seφentine circumferential bands are in the form of longitudinal connectors 24 which extend between peaks 16 on one band and substantially circumferentially aligned troughs 18 on an adjacent band.
Desirably, circumferentially adjacent connectors 20 are separated by a path along one seφentine circumferential band which traverses at least two peaks of the seφentine circumferential band and by a path along the adjacent seφentine circumferential band which traverses at least two troughs of the adjacent seφentine circumferential band. The invention allows for more peaks or fewer and/or more troughs or fewer troughs between adjacent connectors of any of the embodiments disclosed herein. The stent is further constructed so that in the unexpanded configuration, and desirably in a delivery configuration, peaks of one seφentine circumferential band are substantially circumferentially aligned with troughs of an adjacent seφentine circumferential band.
Because of the unequal strut pair lengths of strut pairs which are opposite one another on adjacent seφentine circumferential bands, on expansion of the stent unconnected peaks and troughs which were substantially circumferentially aligned with one another will be displaced circumferentially relative to one another.
In another embodiment of the invention, as shown in the flat in Fig. lb, adjacent seφentine circumferential bands 20 are interconnected via a plurality of connectors 24 whose first and second ends are circumferentially and longitudinally offset from one another. Desirably, as shown in Fig. lb, connectors 24 are substantially linear. Non-linear connectors, including curved connectors, connectors having curved portions and connectors having angled portions, may also used if space permits. Connectors 24 may be seen in greater detail in Fig. lc which is an enlargement of a portion of the stent of Fig. lb. The connectors are shown with hatch marks in Fig. lc. Although connectors 24 are at an oblique angle relative to the longitudinal axis of the stent, they are, nevertheless, substantially parallel to the longitudinal axis of the stent. It is within the of the invention to provide embodiments in which connectors 24 are disposed at a more substantial angle relative to the longitudinal axis of the stent so that the connectors are not substantially parallel to the longitudinal axis of the stent. The connectors of Fig. lb may also be longer, depending on the separation between adjacent seφentine circumferential bands.
In other respects, the stent of Figs, lb and lc is similar to that of Fig. la. Both stents have three types of struts 14a- 14c of increasing length and width. Both have connected pairs of peaks and trough 16' and 18' as well as unconnected pairs of substantially circumferentially aligned and unconnected peaks 16" and troughs 18". In both stents, the struts are distributed such that on expansion of the stent, unconnected but substantially circumferentially aligned peaks and troughs are displaced relative to one another about the circumference of the stent.
In another embodiment of the invention, as shown in the flat in Fig. 2, each seφentine circumferential band comprises three types of struts of different length, struts 14a- 14c.
With the exception of the distal-most seφentine circumferential band, within a seφentine circumferential band, the peaks are arranged circumferentially in a repeat pattern of two longitudinally aligned adjacent peaks and one shorter peak adjacent to the two aligned peaks. Also, with the exception of the proximal-most seφentine circumferential band, within a seφentine circumferential band, the troughs are arranged circumferentially in a repeat pattern of two longitudinally aligned adjacent troughs and one longer trough adjacent to the two aligned troughs. '
As with the stent of Fig. la, the struts within the seφentine circumferential bands are arranged such that when the stent is in an unexpanded state, peaks on one band are substantially circumferentially aligned with troughs on an adjacent substantially circumferential band. Upon expansion of the stent, peaks and troughs which were substantially circumferentially aligned with one another will be displaced circumferentially relative to one another.
The proximal-most and distal-most seφentine circumferential bands of the stent of Fig. 2 differ from that of Fig. la in that the troughs of the proximal-most seφentine circumferential band are aligned with another and the peaks of the distal- most seφentine circumferential band are aligned with another, unlike in the stent of Fig. la. Moreover, the peaks in the proximal-most seφentine circumferential band are arranged in a repeating pattern of two longer peaks followed by one shorter peak and the troughs in the distal-most seφentine circumferential band are arranged in a repeating pattern of one longer trough and two shorter troughs. The stent of Fig. 2 is similar to the stent of Fig. la in that the number of connections between the adjacent seφentine circumferential bands is constant along the length of the stent. Also, the frequency of connections between the adjacent seφentine circumferential bands is constant along the length of the stent as is the spacing of the connections about the circumference of the stent. Another inventive stent is shown in Fig. 3. The stent of Fig. 3 is similar to the stent of Fig, 2 but differs in that troughs in the proximal-most seφentine circumferential band are not longitudinally aligned with one another. Also, the peaks in the distal-most seφentine circumferential band are not longitudinally aligned -with one another. Rather, the proximal-most and distal-most seφentine circumferential bands of the stent are of the same construction as the remainder of the seφentine circumferential bands in the stent.
Fig. 4 shows a flat view of an inventive stent in an unexpanded configuration. In this figure the unconnected peaks 16" of each band proximal to the distal most band are substantially circumferentially aligned with the unconnected troughs 18" of an adjacent band 20. The struts 14a-c are of three lengths and widths. The stent of Fig. 4 is shown in an expanded configuration in Fig. 5. In the expanded configuration, unconnected peaks 16" and unconnected troughs 18" which were previously substantially circumferentially aligned with one another are now displaced circumferentially, relative to one another. A similar circumferential displacement between unconnected but substantially circumferentially aligned peaks and troughs occurs in the other stents disclosed herein as well.
An inventive stent with special ends is shown in the flat in Figs. 6a and 6b. Unlike with the stents of the previous figures, the stent of Figs. 6a and 6b has an increased number of connectors extending between adjacent seφentine circumferential bands at the ends of the stent. Specifically, each peak on the proximal-most seφentine circumferential band is connected to a trough on the adjacent seφentine circumferential band and each trough on the distal-most seφentine circumferential band is connected to a peak on the adjacent seφentine circumferential band. The connectivity results in plurality of larger and smaller substantially diamond-shaped cells 25a and 25b (shown with hatching) which serves to stabilize the end of the stent.
The stent of Figs. 6a and 6b may be modified in numerous ways. In one modification, only one end of the stent is provided with the additional connectors so that only one end of the stent has the large cell/small cell structure shown in Figs. 6a and 6b. In another modification, at one or both ends of the stent three or more adjacent seφentine circumferential bands are interconnected with additional or fewer connectors as compared with the remainder of the stent. Thus, the resulting stent has multiple adjacent rows of large and small diamond cells at one or both ends of the stent. Also, the ratio of connectors to peaks may be other than the 1:1 ratio provided at the end of the stent of Fig. 6a and other than the ratio of 1 :3 provided in Fig. la.
The stent of Fig. la is designed such that the expansion proceeds in the same way whether the stent is deployed from the proximal to the distal end or vice versa. The stents of Figs. 2-6, on the other, expand differently depending on whether the stent is expanded from the proximal to the distal end or vice versa.
In the middle seφentine circumferential bands of the stent of Fig. 2, deployment from the distal end 10 of the stent results in the deployment of the unconnected peaks 16" of each seφentine circumferential band 20 before the deployment of the connected peaks 16'. Deployment from the proximal end 12 of the stent results in the deployment of the connected troughs 18' of each band 20 before the deployment of the unconnected troughs 18".
In the inventive stents disclosed herein, each seφentine circumferential band is characterized by a path length about the periphery of the stent. This path length corresponds to the length that the band would have if cut open and stretched out into a line. Desirably, as shown in Figs. 1-6, each of the seφentine circumferential bands is of the same total pathlength. The invention also contemplates embodiment in which the seφentine bands are not all of the same pathlength. To the extent that the stent has pathlengths of different length, the different length pathways are desirably provided only at one or both ends of the stent. In the inventive stents disclosed in Figs. 1-6, the seφentine circumferential bands all have the same number of peaks and the same number of troughs. Although the invention also contemplates embodiments which include bands of different numbers of peaks and troughs, to the extent that such bands are present, it is desirable that they be present only at one or both ends of the stent. To the extent that the stents of Figs. 1-6 are considered to comprise seφentine circumferential bands, each of which comprises a plurality of interconnected struts, it is noted that all of the bands have the same number of struts. The invention also contemplates embodiments having the presence of some seφentine circumferential bands which have more or fewer struts than other of the seφentine circumferential bands. Desirably, however, the bands having different numbers of struts are provided only at one or both ends of the stent.
The inventive stents may also be considered to compromise a plurality of interconnected cells. As shown in Fig. la, the stent comprises a plurality of rows of interconnected cells 27' and 27". Cells 27' and 27"are identical in area and shape but extend in opposite helical directions about the longitudinal axis of the stent. Each cell is defined by first and second paths which are connected to one another by connectors. Cell 27' for example, has a first path 31' and a second path 33' connected by connectors 24. The first path forms a part of a seφentine circumferential band and the second path form a part of another seφentine circumferential band. In the embodiment of Figs. 1 -6, the first and second paths at the ends of a cell are of the same pathlength. The first and second paths of a cell also have the same number of struts. However, the arrangement of the struts in the first and second paths differ from one another resulting in peak- trough pairs within a cell which are substantially circumferentially aligned in an unexpanded state and desirably in a delivery configuration on a catheter and which are circumferentially displaced relative to one another on expansion of the stent.
In the embodiment of Fig. lb, cells 27' and 27" are oriented in opposite helical directions about the longitudinal axis of the stent. In the embodiment of Fig. 2, three types of cells 27', 27" and 27'" are present as a result of the alignment of the peaks at one end and the troughs at the other end of the stent. In the embodiments of Figs. 3 and 4, only a single type of cell 27' is present. In the embodiment of Figs 6a and 6b, cells 25a and 25b at the ends of the stent are substantially diamond shape whereas the remaining cells 27' are not substantially diamond shaped.
The inventive stents of Figs. 1-6 allow for pairs of unconnected peaks and troughs on adjacent bands to be substantially aligned in an unexpanded state, and desirably in the delivery configuration, while allowing for the unconnected peaks and troughs to be displaced circumferentially relative to one another on expansion of the stent. This is achieved, using seφentine circumferential bands of equal path length and/or equal numbers of peaks, by arranging the struts of the stent such that the path length between a connected peak and a circumferentially adjacent connected peak on a first seφentine band is different from the path length along an adjacent seφentine band between the corresponding connected trough and the corresponding unconnected trough. Differently stated, the summed length of the two struts immediately circumferentially adjacent to a connected peak is different than the summed length of the two struts immediately adjacent the corresponding connected trough as the circumference of the stent is traversed in a given direction. By employing bands with the same number of peaks to achieve the displacement on expansion of the stent, the use of connectors which are substantially angled relative to the longitudinal axis may be avoided. Moreover, more uniform coverage of the vessel may be achieved as compared with stents having bands of differing numbers of peaks.
The invention is also directed to a stent having a proximal end and a distal end comprising a plurality of connected seφentine circumferential bands. Each seφentine band comprises a plurality of struts arranged in alternating peaks and troughs. Adjacent seφentine circumferential bands are connected via a plurality of longitudinal connectors extending between peaks on one seφentine circumferential band and troughs on the seφentine circumferential band adjacent thereto. The struts of the seφentine bands are arranged such that on expansion of the stent, peaks and troughs which are substantially circumferentially aligned with one another, but not connected with one another, on adjacent seφentine circumferential bands are circumferentially displaced from one another. Typically, each band comprises a repeating pattern of three or more struts of different lengths. The struts of different lengths are also typically of different widths. Desirably, the stent is constructed and arranged to be self- expanding.
The invention is also directed to a stent comprising at least one circumferential seφentine band disposed about a longitudinal axis, the seφentine band comprising a plurality of struts, adjacent struts connected one to the other, the seφentine band having alternating peaks and troughs, the seφentine band including at least three peaks which are circumferentially and longitudinally offset from one another. Typically, the stent will comprise a plurality of the circumferential seφentine band, adjacent circumferential seφentine bands connected to one another. Desirably, adjacent circumferential seφentine bands are connected to one another via two or more longitudinal connectors. More desirably, the stent is constructed such that unconnected peaks and troughs which are substantially chcumferentially aligned prior to expansion of the stent are circumferentially displaced from one another on expansion of the stent.
The invention is also directed to a stent comprising at least one seφentine circumferential band which comprises a repeat pattern of three or more struts of different lengths. Desirably, the stent comprises a plurality of the seφentine band, adjacent bands connected to one another. The struts are arranged in a pattern of alternating peaks and troughs.
The invention is also directed to a stent comprising at least two seφentine bands including a first seφentine band and a second seφentine band, each seφentine band having alternating peaks and troughs, the first seφentine band including connected peaks and unconnected peaks, the second seφentine band including connected troughs and unconnected froughs. The peaks of the first seφentine band are substantially longitudinally aligned with the troughs of the second seφentine band when the stent is in an unexpanded state. The connected peaks are connected to the connected troughs with connectors, each of the connectors having two ends which are substantially longitudinally aligned with one another in at least the unexpanded state. The unconnected peaks of each band become circumferentially displaced from the unconnected froughs of an adjacent seφentine circumferential band, and the unconnected troughs of each seφentine circumferential band become circumferentially displaced from the unconnected peaks of each seφentine circumferential band on expansion of the stent.
The invention is also directed to a stent comprising at least two seφentine bands, such as that shown by way of non-limiting example in Figs. 6a and 6b, including a first seφentine band and a second seφentine band. Each seφentine band has alternating peaks and troughs. The first seφentine band includes connected peaks and unconnected peaks, and the second seφentine band includes connected troughs and unconnected troughs. The first and second seφentine bands have an identical number of peaks. The peaks of the first seφentine band are substantially longitudinally aligned with the troughs of the second seφentine band when the stent is in an unexpanded state. The connected peaks are connected to the connected troughs. The unconnected peaks of each band become circumferentially displaced from the unconnected froughs of an adjacent band, and the unconnected troughs of each band become circumferentially displaced from the unconnected peaks of an adjacent band on expansion of the stent. Optionally, the first and second seφentine bands may be of different total pathlength about the stent.
Desirably, as shown in Fig. 6a, the stent comprises a third seφentine band having alternating peaks and troughs. The first, second and third seφentine bands are arranged sequentially along the stent with the first seφentine band and the second seφentine band connected one to the other and defining a plurality of cells therebetween and the second seφentine band and the third seφentine band connected one to the other and defining a plurality of cells therebetween. The first, second and third seφentine bands have the same number of peaks.
More desirably, as shown in Figs. 6a and 6b, tbs stent has a first and second end region and a middle region extending therebetween wherein at least one of the first and second end regions of the stent has a different cell structure from the remainder of the stent. Optionally, the first and second end regions may have a cell structure which differs from one another.
The invention is also directed to helical stents. One or more helical bands may be provided where the peaks and troughs on it are arranged such that some of the peaks are substantially circumferentially aligned and connected to some of the troughs on an adjacent turn of the helical band or on an adjacent helical band and other substantially circumferentially aligned peaks and troughs on adjacent bands or adjacent turns of a band are not connected to one another. On expansion of the stent, the non- connected substantially circumferentially aligned peaks and troughs are chcumferentially displaced from one another. This may be achieved with an appropriate arrangement of struts.
Any of the inventive stents disclosed herein may also be provided in a 'jelly roll' configuration. For example, the flat pattern of Fig. 1 may be rolled into a tube without securing the longitudinal edges to one another. Such a stent would be deployed by unrolling and expansion of the cells or bands which extend about the longitudinal axis of the stent. An example of such a stent is disclosed in WO0132099.
The inventive stents disclosed herein may also be provided in an embodiments in which the longitudinal connectors may be shorter or longer than those shown in Fig. 1 a or any of the other figures disclosed herein. For example, in one embodiment, where adjacent bands have the same number of peaks, facing peaks and troughs which are connected to one another may abut one another and the connector may be in the form of a small weld or an overlap region between the facing peak and frough. Also, connector which are curved may be used to connect facing peaks and troughs. The connectors may also be located offset from the peaks and troughs.
The invention is also directed to stents such as those disclosed herein with sidebranch access. Such a stent may be provided by omitting one or more struts in one or more desired regions of the stent. Sidebranch access may also be provided by omitting a first seφentine band and providing connectors between some, but not all of the peaks and troughs of the resulting adjacent second seφentine bands. Sidebranch access may further be achieved in any of the inventive stents disclosed herein by alternating the location of connectors between adjacent seφentine bands. For example, where it is desirable to provide for sidebranch access, fewer connections between adjacent bands may be provided. Sidebranch access may also be provided by including adjacent seφentine bands of different total pathlength. In such a case, it is desirable although not necessary that the adjancent seφentine bands have the same number of peaks.
The inventive stents disclosed herein may also be used in bifurcated stents. The trunk and/or any of the branches may be provided with stents having the novel designs disclosed herein.
Any of the inventive stents disclosed above may be provided with a uniform diameter or may taper in portions or along the entire length of the stent. Also, the width and/or thickness of the various portions of the inventive stents may increase or decrease along a given portion of the stent. For example, the width and/or thickness of the struts, seφentine bands and/or longitudinal connectors may increase or decrease along portions of the stent or along the entire length of the stent. The amplitude and/or wavelength of several successive first seφentine bands may remain constant while the width and/or thickness of the successive first seφentine bands decreases. Similarly, the amplitude and/or wavelength of several successive second seφentine bands may remain constant while the width and/or thickness of the successive second seφentine bands decreases. In other embodiments of the inventive stents disclosed herein, the amplitude and/or wavelength of several successive first seφentine bands may decrease or increase while the width and/or thickness of the successive first seφentine bands remains constant. Similarly, the amplitude and/or wavelength of several successive second seφentine bands may or decrease or increase while the width and/or thickness of the successive second seφentine bands remain constant. The amplitude of the stent could also be increased or decrease along with the thickness and/or width of the stent. The inventive stents may be manufactured using known stent manufacturing techniques. Suitable methods for manufacturing the inventive stents include laser cutting, chemical etching or stamping of a tube. The inventive stents may also be manufactured by laser cutting, chemically etching, stamping a flat sheet, rolling the sheet and welding the sheet, by electrode discharge machining, or by molding the stent with the desired design. Any suitable stent material may be used in the manufacture of the inventive stents. Examples of such materials include polymeric materials, metals, ceramics and composites. Suitable polymeric materials include thermotropic liquid crystal polymers (LCP's). Where the stent is made of metal, the metal may be stainless steel, cobalt chrome alloys such as elgiloy, tantalum o other plastically deformable metals. Other suitable metals include shape-memory metals such as nickel titanium alloys generically known as "nitinol", platinum/tungsten alloys and titanium alloys. The invention also contemplates the use of more than one material in the inventive stents. For example, the first seφentine band and the second seφentine band may be made of different materials. Optionally, the connectors may be made of a different material than the first and/or second seφentine bands.
The inventive stents desirably are provided in self-expanding form. To that end, they may be constructed from shape memory materials including Nitinol. The self-expanding embodiments of the invention allow for a controlled expansion of the stent as explained below. Typically, self-expanding stents are restrained on a catheter in an unexpanded configuration via a sheath. As the sheath is withdrawn, the newly freed portions of the stent will self-expand. Because the peaks within a seφentine cylindrical bands extend to different longitudinal extent, each seφentine circumferential band will be freed from the sheath in several waves - the first wave of peaks, corresponding to the longest peaks will expand first, followed by a wave of peaks which are shorter expanding until the seφentine is expanded.
The inventive stents may also be provided in balloon expandable form, or as a hybrid, having self-expanding characteristics and balloon expandable characteristics. The inventive stents may include suitable radiopaque coatings. For example, the stents may be coated with gold or other noble metals or sputtered with tantalum or other metals. The stents may also be made directly from a radiopaque material to obviate the need for a radiopaque coating or may be made of a material having a radiopaque inner core. Other radiopaque metals which may be used include platinum, platinum tungsten, palladium, platinum iridium, rhodium, tantalum, or alloys or composites of these metals.
The inventive stents may also be provided with various bio-compatible coatings to enhance various properties of the stent. For example, the inventive stents may be provided with lubricious coatings. The inventive stents may also be provided with drug-containing coatings which release drugs over time.
The inventive stents may also be provided with a sugar or more generally a carbohydrate and/or a gelatin to maintain the stent on a balloon during delivery of the stent to a desired bodily location. Other suitable compounds for treating the stent include biodegradable polymers and polymers which are dissolvable in bodily fluids.
Portions of the interior and/or exterior of the stent may be coated or impregnated with the compound. Mechanical retention devices may also be used to maintain the stent on the balloon during delivery.
The inventive stents may also be used as the framework for a graft or may have a liner disposed therein. Suitable coverings and liners include nylon, collagen, PTFE and expanded PTFE, polyethylene terephthalate and KENLAR, or any of the materials disclosed in US 5,824,046 and US 5,755,770. More generally, any known graft material may be used including synthetic polymers such as polyethylene, polypropylene, polyurethane, polyglycolic acid, polyesters, polyamides, their mixtures, blends, copolymers, mixtures, blends and copolymers.
The inventive stents may find use in coronary arteries, renal arteries, peripheral arteries including illiac arteries, arteries of the neck and cerebral arteries. The stents of the present invention, however, are not limited to use in the vascular system and may also be advantageously employed in other body structures, including but not limited to arteries, veins, biliary ducts, urethras, fallopian tubes, bronchial tubes, the trachea, the esophagus and the prostate.
The invention is also directed to stent delivery catheters with stents such as those disclosed herein disposed about a portion of the catheter.
The invention is also directed to methods of delivering any of the stents disclosed herein. The methods comprise delivering a catheter with an inventive stent disclosed herein disposed thereabout to a desired bodily location and expanding the stent or allowing the stent to expand. In the latter case, the stent is self-expanding and a sheath which restrains the stent is removed from about the stent. As the sheath is removed, waves of peaks from a given seφentine circumferential band are freed to self- expand. Upon deployment of the stent, the catheter is removed from the body.
The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the claims where the term "comprising" means "including, but not limited to". Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims. In addition to the specific embodiments claimed below, the invention is also directed to other embodiments having any other possible combination of the dependent features claimed below. As such, the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims. For instance, for puφoses of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below (e.g. claim 3 may be taken as alternatively dependent from claim 2; claim 4 may be taken as alternatively dependent on claim 1, claim 5 may be taken as alternatively dependent from claims 1-4, claim 6 may be taken as alternatively dependent from claims 1-5; etc.). The above Examples and disclosure are intended to be illustrative and not exhaustive. These examples and this description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto. This PCT application claims priority from US Application No. 10/269,111, filed on October 9, 2002, the entire contents of which is hereby incoφorated by reference.

Claims

What is claimed is as follows:
1. A stent comprising: at least two seφentine circumferential bands including a first seφentine circumferential band and a second seφentine circumferential band, each seφentine circumferential band having alternating peaks and troughs, there being a plurality of unconnected peak-trough pairs, each unconnected peak-trough pair comprising a peak on the first seφentine circumferential band and a trough on the second serpentine cfrcumferential band which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, the trough not connected to the peak, there being a plurality of connected peak-trough pairs, each connected peak- trough pair comprising a peak on the first seφentine circumferential band and a trough on the second seφentine circumferential band which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, the trough connected to the peak, the distance along the first seφentine circumferential band between each peak of a connected peak-trough pair and an adjacent peak of an unconnected peak-trough pair differing from the distance along the second seφentine circumferential band between the frough of the connected-trough pair and an adjacent frough of an unconnected peak-trough pair, the adjacent peak substantially opposite the adjacent trough.
2. The stent of claim 1 wherein the first and second seφentine circumferential bands are connected to one another via a plurality of longitudinal connectors.
3. The stent of claim 1 comprising three or more of the seφentine circumferential bands, adjacent seφentine circumferential bands connected one to the other, there being a plurality of unconnected peak-trough pairs along adjacent seφentine circumferential bands, each unconnected peak-trough pair comprising a peak on one seφentine circumferential band and a frough on the adjacent seφentine circumferential band which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, the trough not connected to the peak, there being a plurality of connected peak-trough pairs along adjacent seφentine circumferential bands, each connected peak-trough pair comprising a peak on one seφentine circumferential band and a trough on the adjacent seφentine circumferential band which is substantially chcumferentially aligned with the peak when the stent is in an unexpanded configuration, the trough connected to the peak, the distance along a seφentine circumferential band between each peak of a connected peak-trough pair and an adjacent peak of an unconnected peak-trough pair differing from the distance along the adjacent seφentine circumferential band between the trough of the connected-trough pair and an adjacent trough of an unconnected peak- trough pair, the adjacent peak substantially opposite the adjacent trough.
4. The stent of claim 3 wherein the adjacent seφentine circumferential bands are connected to one another via a plurality of longitudinal connectors.
5. The stent of claim 4 wherein circumferentially adj acent connected peak-frough pairs are separated by at least two substantially circumferentially aligned peaks and troughs.
6. The stent of claim 1 wherein circumferentially adjacent connected peak-frough pairs are separated by at least two substantially circumferentially aligned peaks and troughs.
7. The stent of claim 1 wherein the seφentine circumferential bands are each constructed of a repeating pattern of struts of at least three different lengths.
8. The stent of claim 7 wherein the longest of the struts is wider than the other struts.
9. The stent of claim 8 wherein the shortest of the struts is narrower than the other struts.
10. The stent of claim 1 wherein the peaks of the seφentine circumferential bands include short peaks, intermediate peaks and long peaks, the long peaks extending distally beyond the intermediate and short peaks in the seφentine circumferential band and the troughs of the seφentine circumferential bands include short troughs, intermediate troughs and long troughs, the long troughs extending proximally beyond the intermediate and short froughs in the seφentine circumferential band.
11. The stent of claim 1 wherein the peaks of the seφentine circumferential bands include short peaks and long peaks, the long peaks extending distally beyond the short peaks in the seφentine circumferential band and the troughs of the seφentine circumferential bands include short troughs and long troughs, the long troughs extending proximally beyond the short troughs in the seφentine circumferential band, the long and short peaks of a seφentine circumferential band arranged in repeating pattern of two long peaks and one short peak.
12. The stent of claim 11 wherein the long and short troughs of a seφentine circumferential band are arranged in a repeating pattern of two short troughs and one long trough.
13. The stent of claim 1 further comprising at least one end band, the end band being in the form of a seφentine band the peaks or troughs of which are all longitudinally aligned with one another.
14. The stent of claim 1 further comprising two end bands, a proximal end band and a distal end band, the proximal end band being in the form of a seφentine band having alternating peaks and froughs, froughs of which are all longitudinally aligned with one another, the distal end band being in the form of a seφentine band having alternating peaks and troughs, peaks of which are all longitudinally aligned with one another.
15. The stent of claim 1 constructed and arranged to be self-expanding.
16. A stent, comprising: a plurality of seφentine circumferential bands comprising alternating peaks and troughs, adjacent seφentine circumferential bands connected to one another, the seφentine circumferential bands including a first seφentine circumferential band, a second seφentine circumferential band and a third seφentine circumferential band, the first seφentine circumferential band including high peaks and low peaks, the second serpentine circumferential band including high peaks and low peaks, high troughs and low troughs, the third seφentine circumferential band including high troughs and low troughs, the high peaks of the first seφentine circumferential band substantially circumferentially aligned with the low froughs of the second seφentine circumferential band and the low peaks of the first seφentine circumferential band substantially circumferentially aligned with the high troughs of the second seφentine circumferential band, the high peaks of the second seφentine circumferential band substantially circumferentially aligned with the low froughs of the third seφentine circumferential band and the low peaks of the second seφentine circumferential band substantially circumferentially aligned with the high troughs of the third seφentine circumferential band, wherein the first seφentine circumferential band is interlaced with the second seφentine circumferential band and the second seφentine circumferential band is interlaced with the third seφentine circumferential band.
17. The stent of claim 16 constructed and arranged to be self-expanding.
18. The stent of claim 16 further comprising at least one end band, the end band being in the form of a seφentine band the peaks or troughs of which are all longitudinally aligned with one another.
19. The stent of claim 16 further comprising two end bands, a proximal end band and a distal end band, the proximal end band being in the form of a seφentine band having alternating peaks and froughs, troughs of which are all longitudinally aligned with one another, the distal end band being in the form of a seφentine band having alternating peaks and troughs, peaks of which are all longitudinally aligned with one another.
20. The stent of claim 16 wherein adjacent seφentine circumferential bands are connected to one another via a plurality of longitudinal connectors extending between substantially chcumferentially aligned peaks and troughs.
21. The stent of claim 16, there being a plurality of unconnected peak-trough pairs, each unconnected peak-trough pair comprising a peak on a seφentine circumferential band and a frough on the seφentine circumferential band adjacent thereto which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, the trough not connected to the peak, there being a plurality of connected peak-trough pairs, each connected peak- trough pair comprising a peak on a seφentine circumferential band and a trough on the seφentine circumferential band adjacent thereto which is substantially circumferentially aligned with the peak when the stent is in an unexpanded configuration, the trough connected to the peak, the distance along the serpentine circumferential band between each peak of a connected peak-trough pair and an adjacent peak of an unconnected peak-trough pair differing from the distance along the adjacent serpentine circumferential band between the trough of the connected-trough pair and an adj acent frough of an unconnected peak- trough pair, the adjacent peak substantially opposite the adjacent trough.
22. The stent of claim 16 wherein the seφentine circumferential bands are each constructed of a repeating pattern of struts of at least three different lengths.
23. The stent of claim 22 wherein the longest of the struts is wider than the other struts.
24. The stent of claim 23 wherein the shortest of the struts is narrower than the other struts.
25. A stent having a proximal end and a distal end comprising a plurality of connected seφentine circumferential bands, each seφentine band comprising a plurality of struts arranged in alternating peaks and troughs, adjacent seφentine circumferential bands connected via a plurality of longitudinal connectors extending between peaks on one seφentine circumferential band and troughs on the seφentine circumferential band adjacent thereto, the struts of the seφentine bands arranged such that on expansion of the stent, peaks and froughs which are substantially circumferentially aligned with one another, but not connected with one another, on adjacent seφentine circumferential bands are circumferentially displaced from one another.
26. The stent of claim 25 wherein each band comprises a repeating pattern of three or more struts of different lengths.
27. The stent of claim 26 wherein the struts of different lengths are also of different widths.
28. The stent of claim 25 constructed and arranged to be self-expanding.
29. A stent comprising: at least one circumferential seφentine band disposed about a longitudinal axis, the seφentine band comprising a plurality of struts, adjacent struts connected one to the other, the seφentine band having alternating peaks and troughs, the seφentine band including at least three peaks which are circumferentially and longitudinally offset from one another.
30. The stent of claim 29 comprising a plurality of the circumferential seφentine band, adjacent circumferential seφentine bands connected to one another.
31. The stent of claim 29 wherein adjacent cfrcumferential seφentine bands are connected to one another via two or more longitudinal connectors.
32. The stent of claim 31 wherein peaks and troughs which are substantially circumferentially aligned prior to expansion of the stent and which are not connected to one another are circumferentially displaced from one another on expansion of the stent.
33. A stent comprising at least one seφentine circumferential band comprising a repeat pattern of three or more struts of different lengths arranged in a pattern of alternating peaks and froughs.
34. The stent of claim 33 comprising a plurality of the seφentine band, adjacent bands connected to one another.
35. A stent comprising: at least two seφentine bands including a first seφentine band and a second seφentine band, each seφentine band having alternating peaks and froughs, the first seφentine band including connected peaks and unconnected peaks, the second seφentine band including connected troughs and unconnected troughs, the peaks of the first seφentine band being substantially longitudinally aligned with the troughs of the second seφentine band when the stent is in an unexpanded state, the connected peaks connected to the connected troughs with connectors, each of the connectors having two ends which are substantially circumferentially aligned with one another wherein the unconnected peaks of each band become chcumferentially displaced from the unconnected troughs of an adjacent band, and the unconnected troughs of each band become circumferentially displaced from the unconnected peaks of an adj acent band.
36. The stent of claim 35 wherein each band is comprised of at least 3 types of struts of dissimilar lengths.
37. The stent of claim 35 wherein there are more than two seφentine bands.
38. A stent comprising: at least two seφentine bands including a first seφentine band and a second seφentine band, each seφentine band having alternating peaks and troughs, the first seφentine band including connected peaks and unconnected peaks, the second seφentine band including connected troughs and unconnected troughs, the first and second seφentine bands having an identical number of peaks, the peaks of the first seφentine band being substantially longitudinally aligned with the troughs of the second seφentine band when the stent is in an unexpanded state, the connected peaks connected to the connected troughs, wherein the unconnected peaks of each band become circumferentially displaced from the unconnected troughs of an adjacent band, and the unconnected troughs of each band become circumferentially displaced from the unconnected peaks of an adjacent band on expansion of the stent.
39. The stent of claim 38 comprising a third seφentine band having alternating peaks and troughs, the first, second and third seφentine bands arranged sequentially along the stent, the first seφentine band and the second seφentine band connected one to the other and defining a plurality of cells therebetween, the second seφentine band and the thhd seφentine band connected one to the other and defining a plurality of cells therebetween, the first, second and third seφentine bands having the same number of peaks.
40. The stent of claim 39 having a first and second end region and a middle region extending therebetween, wherein at least one of the first and second end regions of the stent has a different cell structure from the remainder of the stent.
41. The stent of claim 40 wherein the first and second end regions have a cell structure which differs from one another.
42. The stent of claim 38 wherein the first seφentine band and the second seφentine band are of different total pafhlengths about the periphery of the stent.
PCT/US2003/029434 2002-10-09 2003-09-17 Stent with improved flexibility WO2004032802A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2003272556A AU2003272556A1 (en) 2002-10-09 2003-09-17 Stent with improved flexibility
EP03754743A EP1567088B1 (en) 2002-10-09 2003-09-17 Stent with improved flexibility
DE60324833T DE60324833D1 (en) 2002-10-09 2003-09-17 STENT WITH IMPROVED FLEXIBILITY
CA2495000A CA2495000C (en) 2002-10-09 2003-09-17 Stent with improved flexibility
JP2004543316A JP2006501942A (en) 2002-10-09 2003-09-17 Stent with improved flexibility

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/269,111 US7223283B2 (en) 2002-10-09 2002-10-09 Stent with improved flexibility
US10/269,111 2002-10-09

Publications (2)

Publication Number Publication Date
WO2004032802A2 true WO2004032802A2 (en) 2004-04-22
WO2004032802A3 WO2004032802A3 (en) 2004-06-24

Family

ID=32068704

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/029434 WO2004032802A2 (en) 2002-10-09 2003-09-17 Stent with improved flexibility

Country Status (8)

Country Link
US (2) US7223283B2 (en)
EP (1) EP1567088B1 (en)
JP (1) JP2006501942A (en)
AT (1) ATE414490T1 (en)
AU (1) AU2003272556A1 (en)
CA (1) CA2495000C (en)
DE (1) DE60324833D1 (en)
WO (1) WO2004032802A2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2193766A2 (en) 2006-08-21 2010-06-09 Angiomed GmbH & Co. Medizintechnik KG Self-expanding Stent
EP1572028B1 (en) * 2002-10-09 2010-07-21 Boston Scientific Limited Intraluminal medical device having improved visibility
US8403978B2 (en) 2006-05-17 2013-03-26 C. R. Bard, Inc. Bend-capable tubular prosthesis
US8475520B2 (en) 2006-12-06 2013-07-02 C. R. Bard, Inc. Stenting ring with marker
US8500793B2 (en) 2006-09-07 2013-08-06 C. R. Bard, Inc. Helical implant having different ends
US8518101B2 (en) 2007-04-03 2013-08-27 C. R. Bard, Inc. Bendable stent
USRE44463E1 (en) 2000-08-18 2013-08-27 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
US8551156B2 (en) 2006-11-10 2013-10-08 C. R. Bard, Inc. Stent
US8574286B2 (en) 2006-05-18 2013-11-05 C. R. Bard, Inc. Bend-capable stent prosthesis
US8721709B2 (en) 2007-09-07 2014-05-13 C. R. Bard, Inc. Self-expansible stent with radiopaque markers and method of making such a stent
EP2744450A1 (en) * 2011-11-15 2014-06-25 Abbott Cardiovascular Systems, Inc. Offset peak-to-peak stent pattern
US9254207B2 (en) 2006-08-29 2016-02-09 C.R. Bard, Inc. Annular mesh

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0121980D0 (en) 2001-09-11 2001-10-31 Cathnet Science Holding As Expandable stent
US7182779B2 (en) 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US20030135266A1 (en) 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7147656B2 (en) 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7351255B2 (en) 2001-12-03 2008-04-01 Xtent, Inc. Stent delivery apparatus and method
US7309350B2 (en) 2001-12-03 2007-12-18 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US20040186551A1 (en) 2003-01-17 2004-09-23 Xtent, Inc. Multiple independent nested stent structures and methods for their preparation and deployment
US7223283B2 (en) 2002-10-09 2007-05-29 Boston Scientific Scimed, Inc. Stent with improved flexibility
US7241308B2 (en) 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
US7326236B2 (en) 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US7323006B2 (en) 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US20050288766A1 (en) * 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8663307B2 (en) * 2005-09-02 2014-03-04 Medtronic Vascular, Inc. Endoluminal prosthesis
US7404823B2 (en) * 2005-10-31 2008-07-29 Boston Scientific Scimed, Inc. Stent configurations
US7381217B2 (en) * 2005-12-23 2008-06-03 Boston Scientific Scimed, Inc. Serpentine stent pattern
JP5042244B2 (en) * 2006-02-27 2012-10-03 ウィリアム・エイ・クック・オーストラリア・プロプライエタリー・リミテッド Combined stent graft introducer and stent graft
AU2007227000A1 (en) 2006-03-20 2007-09-27 Xtent, Inc. Apparatus and methods for deployment of linked prosthetic segments
US8043358B2 (en) * 2006-03-29 2011-10-25 Boston Scientific Scimed, Inc. Stent with overlap and high extension
US8348991B2 (en) * 2006-03-29 2013-01-08 Boston Scientific Scimed, Inc. Stent with overlap and high expansion
US20070251895A1 (en) * 2006-05-01 2007-11-01 Griffin Fe P Shoe hanger
US8834554B2 (en) * 2006-08-22 2014-09-16 Abbott Cardiovascular Systems Inc. Intravascular stent
US8414637B2 (en) * 2006-09-08 2013-04-09 Boston Scientific Scimed, Inc. Stent
US7638159B2 (en) * 2006-09-12 2009-12-29 Boston Scientific Scimed, Inc. Liquid masking for selective coating of a stent
US8211163B2 (en) * 2006-09-13 2012-07-03 Boston Scientific Scimed, Inc. Hybrid symmetrical stent designs
US8182890B2 (en) * 2007-01-19 2012-05-22 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US8814930B2 (en) 2007-01-19 2014-08-26 Elixir Medical Corporation Biodegradable endoprosthesis and methods for their fabrication
US20130150943A1 (en) 2007-01-19 2013-06-13 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US20080199510A1 (en) 2007-02-20 2008-08-21 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8512392B2 (en) * 2007-03-09 2013-08-20 Boston Scientific Scimed, Inc. Stent design with struts of various angles and stiffness
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20080319534A1 (en) * 2007-06-22 2008-12-25 Medtronic Vascular, Inc. Stent With Improved Mechanical Properties
US7867273B2 (en) * 2007-06-27 2011-01-11 Abbott Laboratories Endoprostheses for peripheral arteries and other body vessels
US8333795B2 (en) * 2007-08-27 2012-12-18 Boston Scientific Scimed, Inc. Bulging balloon for bifurcation catheter assembly and methods
US20090069878A1 (en) * 2007-08-27 2009-03-12 Boston Scientific Scimed, Inc. Bifurcation post-dilatation balloon and methods
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
US9375327B2 (en) 2007-12-12 2016-06-28 Intact Vascular, Inc. Endovascular implant
US7896911B2 (en) 2007-12-12 2011-03-01 Innovasc Llc Device and method for tacking plaque to blood vessel wall
US10022250B2 (en) 2007-12-12 2018-07-17 Intact Vascular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US9603730B2 (en) 2007-12-12 2017-03-28 Intact Vascular, Inc. Endoluminal device and method
US8128677B2 (en) 2007-12-12 2012-03-06 Intact Vascular LLC Device and method for tacking plaque to a blood vessel wall
US9101503B2 (en) * 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US8052738B2 (en) * 2008-03-20 2011-11-08 Medtronic Vascular, Inc. Intraluminal flexible stent device
US8128678B2 (en) * 2008-09-02 2012-03-06 Cook Medical Technologies Llc Stent having less invasive ends and improved radial force
GB0908315D0 (en) * 2009-05-14 2009-06-24 Angiomed Ag Stent
US20110190870A1 (en) * 2009-12-30 2011-08-04 Boston Scientific Scimed, Inc. Covered Stent for Vascular Closure
WO2011123203A1 (en) * 2010-03-29 2011-10-06 Boston Scientific Scimed, Inc. Flexible stent design
EP2658484A1 (en) 2010-12-30 2013-11-06 Boston Scientific Scimed, Inc. Multi stage opening stent designs
CN103391757B (en) 2011-03-03 2016-01-20 波士顿科学国际有限公司 Low strain dynamic high strength support
WO2012119037A1 (en) 2011-03-03 2012-09-07 Boston Scientific Scimed, Inc. Stent with reduced profile
GB201106757D0 (en) * 2011-04-20 2011-06-01 Arterius Ltd A stent
US10285831B2 (en) 2011-06-03 2019-05-14 Intact Vascular, Inc. Endovascular implant
CN107028691B (en) * 2012-01-25 2019-08-16 因特脉管有限公司 Intracavitary unit and method
CN106667630B (en) 2012-05-14 2019-03-29 C·R·巴德公司 Can even inflation bracket
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
US9855156B2 (en) 2014-08-15 2018-01-02 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9259339B1 (en) 2014-08-15 2016-02-16 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9730819B2 (en) 2014-08-15 2017-08-15 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9480588B2 (en) 2014-08-15 2016-11-01 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
US11622872B2 (en) 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
EP3457985B1 (en) 2016-05-16 2021-02-17 Elixir Medical Corporation Uncaging stent
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
CN109966034B (en) * 2017-12-27 2021-08-17 先健科技(深圳)有限公司 Covered stent
CN112773585B (en) * 2020-12-30 2023-11-14 杭州唯强医疗科技有限公司 Implant holder
US20220362043A1 (en) * 2021-05-14 2022-11-17 Numed, Inc. Stent having reduced axial shrinkage upon radial expansion

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000030563A1 (en) * 1998-11-20 2000-06-02 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
WO2002060344A2 (en) * 2000-09-22 2002-08-08 Scimed Life Systems, Inc. Flexible and expandable stent

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443498A (en) * 1991-10-01 1995-08-22 Cook Incorporated Vascular stent and method of making and implanting a vacsular stent
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US6331188B1 (en) 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
US5755770A (en) 1995-01-31 1998-05-26 Boston Scientific Corporatiion Endovascular aortic graft
US6896696B2 (en) 1998-11-20 2005-05-24 Scimed Life Systems, Inc. Flexible and expandable stent
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US5713949A (en) 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
US5824046A (en) 1996-09-27 1998-10-20 Scimed Life Systems, Inc. Covered stent
US5868781A (en) * 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6206911B1 (en) 1996-12-19 2001-03-27 Simcha Milo Stent combination
US6162245A (en) 1997-05-07 2000-12-19 Iowa-India Investments Company Limited Stent valve and stent graft
DE29708879U1 (en) 1997-05-20 1997-07-31 Jomed Implantate Gmbh Coronary stent
US7329277B2 (en) 1997-06-13 2008-02-12 Orbusneich Medical, Inc. Stent having helical elements
EP0884029B1 (en) * 1997-06-13 2004-12-22 Gary J. Becker Expandable intraluminal endoprosthesis
EP0890346A1 (en) * 1997-06-13 1999-01-13 Gary J. Becker Expandable intraluminal endoprosthesis
US6231598B1 (en) 1997-09-24 2001-05-15 Med Institute, Inc. Radially expandable stent
US6190406B1 (en) * 1998-01-09 2001-02-20 Nitinal Development Corporation Intravascular stent having tapered struts
US5935162A (en) 1998-03-16 1999-08-10 Medtronic, Inc. Wire-tubular hybrid stent
US6132461A (en) * 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent with dual support structure
DE19829701C1 (en) * 1998-07-03 2000-03-16 Heraeus Gmbh W C Radially expandable support device IV
US8092514B1 (en) 1998-11-16 2012-01-10 Boston Scientific Scimed, Inc. Stretchable anti-buckling coiled-sheet stent
US6340366B2 (en) 1998-12-08 2002-01-22 Bandula Wijay Stent with nested or overlapping rings
US6355057B1 (en) 1999-01-14 2002-03-12 Medtronic, Inc. Staggered endoluminal stent
US7029492B1 (en) * 1999-03-05 2006-04-18 Terumo Kabushiki Kaisha Implanting stent and dilating device
US6423090B1 (en) 2000-02-11 2002-07-23 Advanced Cardiovascular Systems, Inc. Stent pattern with staged expansion
US7828835B2 (en) 2000-03-01 2010-11-09 Medinol Ltd. Longitudinally flexible stent
JP4754714B2 (en) * 2000-06-01 2011-08-24 テルモ株式会社 Intraluminal indwelling
US6540775B1 (en) 2000-06-30 2003-04-01 Cordis Corporation Ultraflexible open cell stent
US8070792B2 (en) 2000-09-22 2011-12-06 Boston Scientific Scimed, Inc. Stent
US6623518B2 (en) 2001-02-26 2003-09-23 Ev3 Peripheral, Inc. Implant delivery system with interlock
US6955686B2 (en) * 2001-03-01 2005-10-18 Cordis Corporation Flexible stent
US6629994B2 (en) * 2001-06-11 2003-10-07 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6969402B2 (en) * 2002-07-26 2005-11-29 Syntheon, Llc Helical stent having flexible transition zone
US6878162B2 (en) * 2002-08-30 2005-04-12 Edwards Lifesciences Ag Helical stent having improved flexibility and expandability
US7223283B2 (en) 2002-10-09 2007-05-29 Boston Scientific Scimed, Inc. Stent with improved flexibility
US7331986B2 (en) * 2002-10-09 2008-02-19 Boston Scientific Scimed, Inc. Intraluminal medical device having improved visibility
US6846323B2 (en) * 2003-05-15 2005-01-25 Advanced Cardiovascular Systems, Inc. Intravascular stent
US8317855B2 (en) * 2005-05-26 2012-11-27 Boston Scientific Scimed, Inc. Crimpable and expandable side branch cell
US7381217B2 (en) * 2005-12-23 2008-06-03 Boston Scientific Scimed, Inc. Serpentine stent pattern
US8062346B2 (en) * 2007-12-21 2011-11-22 Boston Scientific Scimed, Inc. Flexible stent-graft device having patterned polymeric coverings

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000030563A1 (en) * 1998-11-20 2000-06-02 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
WO2002060344A2 (en) * 2000-09-22 2002-08-08 Scimed Life Systems, Inc. Flexible and expandable stent

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8900290B2 (en) 2000-08-17 2014-12-02 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
US10213327B2 (en) 2000-08-17 2019-02-26 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
US9480587B2 (en) 2000-08-17 2016-11-01 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
USRE44463E1 (en) 2000-08-18 2013-08-27 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
EP1572028B1 (en) * 2002-10-09 2010-07-21 Boston Scientific Limited Intraluminal medical device having improved visibility
US10849770B2 (en) 2006-05-17 2020-12-01 C. R. Bard, Inc. Bend-capable tubular prosthesis
US8403978B2 (en) 2006-05-17 2013-03-26 C. R. Bard, Inc. Bend-capable tubular prosthesis
US9155642B2 (en) 2006-05-17 2015-10-13 C.R. Bard, Inc. Bend-capable tubular prosthesis
US9364353B2 (en) 2006-05-18 2016-06-14 C.R. Bard, Inc. Bend-capable stent prosthesis
US10231854B2 (en) 2006-05-18 2019-03-19 C. R. Bard, Inc. Bend-capable stent prosthesis
US8574286B2 (en) 2006-05-18 2013-11-05 C. R. Bard, Inc. Bend-capable stent prosthesis
EP2193766A2 (en) 2006-08-21 2010-06-09 Angiomed GmbH & Co. Medizintechnik KG Self-expanding Stent
US8152842B2 (en) 2006-08-21 2012-04-10 C. R. Bard, Inc. Self-expanding stent
US9254207B2 (en) 2006-08-29 2016-02-09 C.R. Bard, Inc. Annular mesh
US8500793B2 (en) 2006-09-07 2013-08-06 C. R. Bard, Inc. Helical implant having different ends
US10500075B2 (en) 2006-11-10 2019-12-10 C. R. Bard, Inc. Stent
US8551156B2 (en) 2006-11-10 2013-10-08 C. R. Bard, Inc. Stent
US9084691B2 (en) 2006-11-10 2015-07-21 C. R. Bard, Inc. Stent
US8475520B2 (en) 2006-12-06 2013-07-02 C. R. Bard, Inc. Stenting ring with marker
US8518101B2 (en) 2007-04-03 2013-08-27 C. R. Bard, Inc. Bendable stent
US9050203B2 (en) 2007-04-03 2015-06-09 C. R. Bard, Inc. Bendable stent
US10016291B2 (en) 2007-09-07 2018-07-10 C. R. Bard, Inc. Self-expansible stent with radiopaque markers and method of making such a stent
US8721709B2 (en) 2007-09-07 2014-05-13 C. R. Bard, Inc. Self-expansible stent with radiopaque markers and method of making such a stent
EP2744450A4 (en) * 2011-11-15 2015-01-07 Abbott Cardiovascular Systems Offset peak-to-peak stent pattern
EP2744450A1 (en) * 2011-11-15 2014-06-25 Abbott Cardiovascular Systems, Inc. Offset peak-to-peak stent pattern

Also Published As

Publication number Publication date
US20040073290A1 (en) 2004-04-15
CA2495000A1 (en) 2004-04-22
AU2003272556A1 (en) 2004-05-04
JP2006501942A (en) 2006-01-19
EP1567088B1 (en) 2008-11-19
CA2495000C (en) 2011-08-02
DE60324833D1 (en) 2009-01-02
US20070233235A1 (en) 2007-10-04
US7842080B2 (en) 2010-11-30
WO2004032802A3 (en) 2004-06-24
EP1567088A2 (en) 2005-08-31
US7223283B2 (en) 2007-05-29
ATE414490T1 (en) 2008-12-15

Similar Documents

Publication Publication Date Title
US7842080B2 (en) Stent with improved flexibility
EP1703859B1 (en) Stent to be deployed on a bend
US8801773B2 (en) Flexible and expandable stent
EP1903998B1 (en) Hybrid stent
EP1796582B1 (en) Expandable framework with overlapping connectors
EP1565129B1 (en) Expandable stents
EP2043567B1 (en) Stent design with variable expansion columns along circumference
EP2059199B1 (en) Longitudinally flexible expandable stent
US9427340B2 (en) Stent with protruding branch portion for bifurcated vessels
US20030105515A1 (en) Stent designs
US20070112418A1 (en) Stent with spiral side-branch support designs
JP2008515538A (en) Non-shortened helical stent
US7988720B2 (en) Longitudinally flexible expandable stent
US7479158B2 (en) Stent with nested flexible connectors for flexibility and crimpability
EP2012716A1 (en) Bifurcated stent with minimally circumferentially projected side branch

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2495000

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004543316

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003754743

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003754743

Country of ref document: EP